APA (7th ed.) Citation

J, P., C, P., M, L., R, T., J, D., D, G., . . . A, G. (2022). Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer. Journal for immunotherapy of cancer, 10(12), . https://doi.org/10.1136/jitc-2022-005443

Chicago Style (17th ed.) Citation

J, Palomero, et al. "Biomarkers of Tumor-reactive CD4+ and CD8+ TILs Associate with Improved Prognosis in Endometrial Cancer." Journal for Immunotherapy of Cancer 10, no. 12 (2022). https://doi.org/10.1136/jitc-2022-005443.

MLA (9th ed.) Citation

J, Palomero, et al. "Biomarkers of Tumor-reactive CD4+ and CD8+ TILs Associate with Improved Prognosis in Endometrial Cancer." Journal for Immunotherapy of Cancer, vol. 10, no. 12, 2022, https://doi.org/10.1136/jitc-2022-005443.